| abstract |
(57) [Summary] (Corrected) [PROBLEMS] To provide a cosmetic or dermatological composition comprising a combination of an elastase inhibitor compound and at least one metalloproteinase inhibitor compound. Kind Code: A1 In addition to modulators of elastase activity (N-acylaminoamide derivatives that inhibit leukocyte elastase), other enzymes that interfere with the integrity of the skin matrix sequence (at least one metalloproteinase inhibitor) Combination with steroids has an effect on both enzymes involved in collagen degradation and enzymes involved in elastin degradation, thereby preventing or treating the signs of skin aging and light aging It becomes. |